Benzyl sulfonamide derivatives useful as MOGAT-2 inhibitors
申请人:Eli Lilly and Company
公开号:US08575352B2
公开(公告)日:2013-11-05
The present invention provides compounds of Formula below:
and analogues thereof where the various substituent groups, R1, R2, R3, R4, R5 A, and X are described herein; or a pharmaceutical salt thereof; a method of treating a condition such as hypertriglyceridemia and a process for preparing the compounds.
BENZYL SULFONAMIDE DERIVATIVES USEFUL AS MOGAT - 2 INHIBITORS
申请人:Eli Lilly and Company
公开号:EP2809651A1
公开(公告)日:2014-12-10
BENZYL SULFONAMIDE DERIVATIVES USEFUL AS MOGAT-2 INHIBITORS
申请人:Eli Lilly and Company
公开号:EP2809651B1
公开(公告)日:2016-06-29
US8575352B2
申请人:——
公开号:US8575352B2
公开(公告)日:2013-11-05
[EN] BENZYL SULFONAMIDE DERIVATIVES USEFUL AS MOGAT - 2 INHIBITORS<br/>[FR] DÉRIVÉS DE BENZYLSULFANILAMIDE UTILISÉS COMME INHIBITEURS -2 MOGAT
申请人:LILLY CO ELI
公开号:WO2013116075A1
公开(公告)日:2013-08-08
The present invention provides compounds of Formula (I) below: and analogues thereof where the various substituent groups, R1, R2, R3, R4, R5 A, and X are described herein; or a pharmaceutical salt thereof; a method of treating a condition such as hypertriglyceridemia and a process for preparing the compounds.